期刊文献+

PNPLA3基因多态性与非酒精性脂肪性肝病肝损伤间相关性的系统评价 被引量:2

Association between the polymorphism of the PNPLA3 rs738409 gene and liver damage and the steatosis of liver:a Meta-analysis
下载PDF
导出
摘要 目的系统评价PNPLA3rs738409基因突变与非酒精性脂肪性肝病肝损伤的相关性。方法计算机检索Pub Med、CNKI、Embase、Ovid数据库,搜索有关PNPLA3rs738409基因多态性与单纯非酒精性肝病肝损伤相关性的横断面研究,检索时限为建库至2017年4月,由2位研究人员独立筛选,提取数据资料后用STATA12.0软件进行Meta分析。结果在PNPLA3rs738409位点发生突变的患者体内,丙氨酸氨基转移酶、天门冬氨酸氨基转移酶水平明显高于未发生突变的人群,而在三酰甘油、胆固醇水平的研究中二者差异无统计学意义(P>0.05)。结论 PNPLA3基因的突变与非酒精性脂肪性肝病肝损伤有密切相关性。 Objective To systematically review the association between PNPLA3 polymorphism and liver damage and the steatosis of liver. Methods Databases including Pub Med, CNKI, Embase and Ovid were searched via electronically from inception to April 2017, cross-sectional studies about the association between the polymorphism of the PNPLA3 rs738409 gene and liver damage and the steatosis of liver were collected. Two reviewers independently screened literature, extracted data and assessed the methodological quality in- cluded studies. Then,Meta-analysis was performed using STATA 12.0 software. Results The results of Me- ta-analysis showed that the level of alanine aminotransferase and aspartate aminotransferase of the patients with PNPLA3 rs738409 gene mutated were distinctly higher than those of normal patients,while the research of triglyceride and total cholesterol showed no difference between the two groups(P〉0.05). Conclusion PNPLA3 polymorphism is closely associated with liver damage and the steatosis of liver.
出处 《检验医学与临床》 CAS 2018年第2期157-160,共4页 Laboratory Medicine and Clinic
基金 国家自然科学基金资助项目(81301507 81401666)
关键词 PNPLA3基因 基因多态性 非酒精性肝病 META分析 PNPLA3 polymorphism non-alcoholic fatty liver Meta-analysis
  • 相关文献

参考文献2

二级参考文献17

  • 1金文胜,潘长玉.国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华内分泌代谢杂志,2005,21(4):412-413. 被引量:158
  • 2Ress C, Kaser S. Mechanisms of intrahepatic triglgceride accunmlation. World Journal of Gastroenterology, 2016, 22(4): 1664- 1673.
  • 3Liu YL, Reeves HL, Burt AD, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Con'tmun, 2014, 5: 4309.
  • 4Coppola N, Rosa Z, Cirillo G, et aI. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism. Liver Int, 2015, 35(8): 1959-1963.
  • 5Dongiovanni P, Petta S, Maglio C, et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology, 2015, 61(2): 500-514.
  • 6Pietiainen V, Lindgren CM, Stefansson K, et al. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. Pediatr Obes, 2016, 11(2): 115-119.
  • 7Petta S, Maida M, Grimaudo S, et al. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. Liver Int, 2016, 36(2): 198-204.
  • 8Milano M, Aghemo A, Dongiovanni P, et al. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. Hepatology, 2015, 62(1): 111-117.
  • 9Sookoian S, Castano GO, Scian R, el al. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology, 2015, 61(2): 515-525.
  • 10Goffredo M, Caprio S, Feldstein AE, et al. Role of the TM6SF2 rs58542926 in the pathogenesis of non-alcoholic pediatric fatty liver disease (NAFLD): A multiethnic study. Hepatology, 2016, 63(1): 117-125.

共引文献14

同被引文献22

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部